# Sanguine BioSciences, Inc. — Form D

Sanguine BioSciences, Inc. of SHERMAN OAKS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2014-11-25. The offering totals $7.0M, of which $5.5M was reported sold. Industry: Other Technology.

## Offering

- Filed: 2014-11-25
- Form: D
- Accession: 0001626185-14-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $5.5M
- Remaining: $1.4M
- Investors: 74
- Date of first sale: 2014-11-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-229065

## Issuer

- Name: Sanguine BioSciences, Inc.
- CIK: 0001626185
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 15335 MORRISON STREET, SUITE 235, SHERMAN OAKS, CA, 91403
- Phone: (310) 893-6763

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Rudiger Hausherr | Director | Sherman Oaks, CA |
| Brian Neman | Director | Sherman Oaks, CA |
| Tim Triche | Director | Sherman Oaks, CA |
| Brian Neman | Executive Officer | Sherman Oaks, CA |
| Randy Socol | Executive Officer | San Diego, CA |

## More

- [CIK 1626185 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1626185&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001626185-14-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.